Company intelligence / Profile preview

Cellmano Biotech

Ownership: Private
Development stage: Commercial

Overview

Cellmano Biotech is a commercial-stage company specializing in custom and large-scale synthesis of research-grade and industrial peptides for pharmaceutical and cosmetic applications. The company does not appear to have its own clinical pipeline but provides high-purity peptides used in various therapeutic areas.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: PeptidesSmall molecule (for peptide-based small molecules)
Industry: Contract Manufacturing Organization

Partnerships

Not explicitly listed; likely partners with pharmaceutical companies as a CMO/peptide supplier.

Beyond the preview

Go deeper on Cellmano Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellmano Biotech.

Explore the full profile